Agilon Health
AGL
198 hedge funds and large institutions have $2.71B invested in Agilon Health in 2024 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 69 increasing their positions, 55 reducing their positions, and 42 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 55
14% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 42
3% more funds holding
Funds holding: 193 → 198 (+5)
0% more call options, than puts
Call options by funds: $15.1M | Put options by funds: $15M
0.53% less ownership
Funds ownership: 4.87% → 4.34% (-0.53%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
56% less capital invested
Capital invested by funds: $6.2B → $2.71B (-$3.49B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$95.3M |
| 2 |
Capital International Investors
Los Angeles,
California
|
+$61.7M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$18.5M |
| 4 |
EGM
Engineers Gate Manager
New York
|
+$7.06M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$5.59M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$232M |
| 2 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$120M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
-$92.7M |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$85.3M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$56.4M |
AGL Hedge Fund Activity: Q1 2024 in Review
198 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Agilon Health (AGL) for Q1 2024, worth a combined $2.71B — down 56% from $6.2B a quarter earlier.
Buyers outnumbered sellers: 48 funds opened new AGL positions and 42 closed out — a net gain of 6 holders — while 69 added to existing stakes and 55 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $95.3M. The largest seller was Morgan Stanley, cutting an estimated $232M.
- 198 institutional investors held Agilon Health (AGL) as of Q1 2024, up from 193 in Q4 2023.
- Funds reported $2.71B of Agilon Health stock for Q1 2024, down 56% quarter-over-quarter.
- 48 funds opened new Agilon Health positions in Q1 2024 and 42 closed out, a net change of +6 holders.
- The largest Agilon Health buyer in Q1 2024 was Wellington Management Group, an estimated $95.3M added.
- The largest Agilon Health seller in Q1 2024 was Morgan Stanley, an estimated $232M sold.
Based on aggregated 13F filings for Q1 2024.